Press release
Adult Malignant Glioma Therapeutics Market Insights into pharmaceutical industry
Adult Malignant Glioma Therapeutics Market: OverviewGlioma is a type of tumor that occurs in brain or spine. It is a group of brain tumor that includes oligodendrogliomas and astrocytomas. Gliomas include all types of brain tumors arising from supportive tissue of the brain. Malignant glioma is the most common type of brain tumor observed in adults globally. Collectively they contribute around 40% of the total cases diagnosed with brain tumor. In the last decade, there has been a consistent rise in the number of people diagnosed with malignant glioma. The American Brain Tumor Association has estimated around 69,720 new cases of brain tumor in 2013. Thus, rising number of people diagnosed with malignant glioma supports the growth of the global adult malignant glioma therapeutics market. Headache, physical weakness, memory loss and seizures are some of the common symptoms of malignant glioma. Thus, with symptoms getting worse size of tumor increases that destroys brain cells, creates swelling in the brain and increases the pressure on skull.
Get Free Sample Research Report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=13211
The global malignant glioma market can be segmented as follows:
By Type of Cell
Astrocytoma
Oligodendroglioma
Ependymoma
Unspecified Glioma
By Grade
Low - grade Gliomas
High - grade Gliomas
By Location
Supratentorial
Infratentorial
Cancer Research U.K. estimated that around 45% of the total primary brain tumor cases are gliomas. There are majorly four types of gliomas such as astrocytoma, oligodendroglioma, ependymoma and unspecified glioma. Astrocytoms is the most common type of glioma diagnosed globally, more than 30% of the total cases diagnosed with brain tumors are astrocytomas. These types of tumors are not curable as they spread easily through normal brain tissue. Astrocytomas are primarily classified on the basis of grades from one to four as per the speed of their growth in brain cells. American Brain Tumor Association have analyzed that around 7% of all the primary brain tumors represent astrocytomas.
Hence, a rising number of people diagnosed with astrocytomas accentuates the uptake of therapeutics for the treatment of the same. Currently, majority of the therapeutics for the treatment of malignant glioma is under clinical trials, key players are engaged in research and development activities.
Adult Malignant Glioma Therapeutics Market: Region-wise Insight
Geographically, North America and Europe accounted for the largest share in the global adult malignant glioma therapeutics market. This dominance was mainly attributed to key players domiciled in these regions coupled with increasing incidences of brain tumor. Brain tumor is the third most common type of cancer in adults in North America. According to North America Brain Tumor Coalition over 44,500 people in the U.S. were diagnosed with primary tumor in the brain in 2014. Thus, rising incidences of primary brain tumor supports the growth of malignant glioma therapeutics market in North America. In addition, increasing healthcare awareness also supported the growth of malignant glioma therapeutics market in North America and European market.
Similarly, Asia Pacific is considered as the most lucrative market for the growth of malignant glioma therapeutics. The growth in Asian market is fueled by the presence of untapped market opportunities due to increasing and expanding healthcare infrastructure in this region. Asia Pacific is considered as an emerging market owing to growing market penetration coupled with increasing number of manufacturers expanding their geographic presence in this region. Thus, all the mentioned factors collectively propel the growth of malignant glioma therapeutics market during the forecast period from 2014 to 2020.
Adult Malignant Glioma Therapeutics Market: Key Players
Major players and universities engaged in the development of therapeutics for the treatment of malignant glioma include Eli Lilly and Company, Insys Therapeutics, Inc., GlaxoSmithKline plc, Amgen, Inc., Duke University, Shinshu University, Medical Research Council, Osaka University and others.
The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge
US Office Contact
Transparency Market Research
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Adult Malignant Glioma Therapeutics Market Insights into pharmaceutical industry here
News-ID: 352485 • Views: …
More Releases from Transparency Market Research

Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 …
The global solar powered agricultural dryer market, valued at US$ 1.6 billion in 2022, is projected to grow at a CAGR of 5.8% from 2023 to 2031, reaching US$ 2.4 billion by the end of 2031. Rising investments in renewable energy, growing awareness of sustainable agricultural practices, and the rapid expansion of the agricultural sector driven by population growth are key factors fueling market growth.
Uncover essential discoveries and trends from…

Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Ra …
The global Technetium‐99m Market was valued at US$ 6.0 Billion in 2023 and is projected to grow at a CAGR of 3.3% from 2024 to 2034, surpassing US$ 8.6 Billion by the end of the forecast period. Advancements in nuclear imaging infrastructure, government-backed healthcare initiatives, and an increasing demand for precise diagnostic procedures are fueling this growth.
Discover essential conclusions and data from our Report in this sample -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77100
Analysts' Viewpoint
The Technetium‐99m…

Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to …
The global Equine Diagnostic Services Market, valued at approximately US$ 168 million in 2019, is projected to expand at a compound annual growth rate (CAGR) of ~5% from 2020 to 2030, reaching around US$ 280 million by 2030. Equine diagnostic services, encompassing tests like genetic, infectious disease, and imaging diagnostics, are critical for managing horse health in veterinary hospitals, clinics, and mobile settings. The market is driven by increasing equine…

Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of …
The digital printing market is experiencing strong growth, driven by rapid technological advancements, rising demand for personalized and on-demand printing, and an increasing focus on sustainable solutions. Digital printing allows for the direct transfer of digital files onto a wide range of substrates, offering high-resolution output with greater speed and flexibility. Its adaptability has led to broad adoption across industries such as packaging, textiles, publishing, and advertising-sectors where customization, efficiency,…
More Releases for Glioma
Glioma Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Glioma Pipeline Insight 2024" report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in the Glioma pipeline landscape. It covers the Glioma Pipeline Drug profiles, including clinical and nonclinical stage products. It also covers the Glioma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Request a sample and discover the recent advances…
Glioma Competitive Landscape 2023 (Updated)
DelveInsight's, "Glioma Competitive Landscape 2023" report provides comprehensive insights about 200+ Glioma companies and 220+ drugs in Glioma Competitive landscape. It covers the Glioma therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Glioma Competitive Landscape Report
• DelveInsight's Glioma report depicts a robust space with 200+ Glioma companies working to develop 220+ pipeline therapies…
Low-Grade Glioma Therapeutics Market - Transforming Futures, Defying Low-Grade G …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Low-Grade Glioma Therapeutics Market.
Low-Grade Glioma Therapeutics Market: https://www.growthplusreports.com/report/lowgrade-glioma-therapeutics-market/9187
The Low-Grade Glioma Therapeutics Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the…
Adult Malignant Glioma Therapeutics Market - Defying the Tumor, Empowering Survi …
Newark, New Castle, USA - new report, titled Adult Malignant Glioma Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Adult Malignant Glioma Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Adult Malignant Glioma Therapeutics market. The report offers…
Glioma pipeline involves 150+ key companies continuously working towards develop …
DelveInsight's, "Glioma Pipeline Insight, 2023," report provides comprehensive insights about 150+ companies and 150+ pipeline drugs in Glioma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Glioma Pipeline Report
• DelveInsight's glioma pipeline report depicts a…
Rising Number of People Diagnosed with Malignant Glioma Supports the Growth of t …
Glioma is a type of tumor that occurs in brain or spine. It is a group of brain tumor that includes oligodendrogliomas and astrocytomas. Gliomas include all types of brain tumors arising from supportive tissue of the brain. Malignant glioma is the most common type of brain tumor observed in adults globally. Collectively they contribute around 40% of the total cases diagnosed with brain tumor. In the last decade, there…